8,593 Shares in Prestige Consumer Healthcare Inc. (NYSE:PBH) Bought by Intech Investment Management LLC

Intech Investment Management LLC purchased a new stake in Prestige Consumer Healthcare Inc. (NYSE:PBH) during the third quarter, according to its most recent filing with the SEC. The fund purchased 8,593 shares of the company’s stock, valued at approximately $620,000.

Other hedge funds have also bought and sold shares of the company. Evergreen Capital Management LLC grew its stake in shares of Prestige Consumer Healthcare by 5.4% in the 2nd quarter. Evergreen Capital Management LLC now owns 3,143 shares of the company’s stock worth $216,000 after buying an additional 160 shares in the last quarter. Miller Howard Investments Inc. NY grew its position in Prestige Consumer Healthcare by 2.2% in the second quarter. Miller Howard Investments Inc. NY now owns 7,762 shares of the company’s stock worth $534,000 after acquiring an additional 165 shares in the last quarter. OLD National Bancorp IN increased its stake in Prestige Consumer Healthcare by 4.4% during the third quarter. OLD National Bancorp IN now owns 3,974 shares of the company’s stock worth $287,000 after acquiring an additional 168 shares during the last quarter. Huntington National Bank raised its position in Prestige Consumer Healthcare by 39.9% during the third quarter. Huntington National Bank now owns 635 shares of the company’s stock valued at $46,000 after purchasing an additional 181 shares during the period. Finally, EverSource Wealth Advisors LLC lifted its stake in shares of Prestige Consumer Healthcare by 80.6% in the 1st quarter. EverSource Wealth Advisors LLC now owns 466 shares of the company’s stock valued at $33,000 after purchasing an additional 208 shares during the last quarter. Hedge funds and other institutional investors own 99.95% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on PBH shares. DA Davidson restated a “buy” rating and issued a $95.00 target price on shares of Prestige Consumer Healthcare in a report on Monday, November 11th. Jefferies Financial Group reissued a “hold” rating and issued a $76.00 price objective (up previously from $70.00) on shares of Prestige Consumer Healthcare in a research note on Tuesday, September 24th. One investment analyst has rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, Prestige Consumer Healthcare presently has an average rating of “Moderate Buy” and an average price target of $83.67.

Insider Activity at Prestige Consumer Healthcare

In other news, insider William P’pool sold 8,987 shares of the stock in a transaction dated Tuesday, November 12th. The shares were sold at an average price of $81.85, for a total value of $735,585.95. Following the completion of the sale, the insider now directly owns 20,058 shares in the company, valued at $1,641,747.30. This represents a 30.94 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Adel Mekhail sold 9,063 shares of the business’s stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of $82.00, for a total value of $743,166.00. Following the transaction, the executive vice president now owns 18,365 shares in the company, valued at approximately $1,505,930. This represents a 33.04 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 38,810 shares of company stock worth $3,187,300 in the last 90 days. Corporate insiders own 1.60% of the company’s stock.

Prestige Consumer Healthcare Trading Up 0.7 %

Shares of Prestige Consumer Healthcare stock opened at $84.77 on Friday. The firm’s 50 day simple moving average is $75.41 and its two-hundred day simple moving average is $71.16. The firm has a market capitalization of $4.19 billion, a price-to-earnings ratio of 20.63, a PEG ratio of 2.37 and a beta of 0.47. Prestige Consumer Healthcare Inc. has a 12-month low of $56.61 and a 12-month high of $86.36. The company has a current ratio of 3.56, a quick ratio of 2.10 and a debt-to-equity ratio of 0.61.

Prestige Consumer Healthcare (NYSE:PBH) last announced its quarterly earnings data on Thursday, November 7th. The company reported $1.09 EPS for the quarter, meeting the consensus estimate of $1.09. The business had revenue of $283.79 million during the quarter, compared to analysts’ expectations of $282.09 million. Prestige Consumer Healthcare had a net margin of 18.54% and a return on equity of 12.23%. The business’s quarterly revenue was down .9% compared to the same quarter last year. During the same period in the previous year, the business posted $1.07 EPS. Analysts predict that Prestige Consumer Healthcare Inc. will post 4.45 EPS for the current year.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.